Mid-Term Assessment of the EU Drugs Strategy 2013-2020 and Final Evaluation of the Action Plan on Drugs 2013-2016: Public consultation on the evaluation of the EU Drugs Strategy: Report of results

Taylor, Jirka; Hoorens, Stijn

G2TT

来源类型	Report
规范类型	报告
DOI	https://doi.org/10.7249/RR1730
来源ID	RR-1730-EC
	Mid-Term Assessment of the EU Drugs Strategy 2013-2020 and Final Evaluation of the Action Plan on Drugs 2013-2016: Public consultation on the evaluation of the EU Drugs Strategy: Report of results
	Jirka Taylor; Stijn Hoorens
发表日期	2016-09-22
出版年	2016
页码	118
语种	英语
结论	Mid-Term Assessment of the EU Drugs Strategy 2013-2020 and Final Evaluation of the Action Plan on Drugs 2013-2016: Public consultation on the evaluation of the EU Drugs Strategy: Report of results \| RAND Skip to page content Objective Analysis. Effective Solutions.
摘要	A mandatory public consultation was conducted to inform the Mid-Term Assessment of the EU Drugs Strategy 2013-2020 and the final evaluation of the EU Action Plan on Drugs 2013-2016. This document reports on the consultation's results.
目录	Chapter One Introduction Chapter Two Demographic profile of consultation respondents Chapter Three Results Chapter Four Other ad-hoc contributions Annex One Additional tables Annex Two Analysis framework for the public consultation Annex Three Public consultation questionnaire
主题	Drug Markets and Supply ; Drug Policy and Trends ; European Union
URL	https://www.rand.org/pubs/research_reports/RR1730.html
来源智库	RAND Corporation (United States)
引用统计
资源类型	智库出版物
条目标识符	http://119.78.100.153/handle/2XGU8XDN/523138
推荐引用方式 GB/T 7714	Jirka Taylor,Stijn Hoorens. Mid-Term Assessment of the EU Drugs Strategy 2013-2020 and Final Evaluation of the Action Plan on Drugs 2013-2016: Public consultation on the evaluation of the EU Drugs Strategy: Report of results. 2016.

条目包含的文件
文件名称/大小	资源类型	版本类型	开放类型	使用许可
RAND_RR1730.pdf（1018KB）	智库出版物		限制开放	CC BY-NC-SA	浏览
x1600182997025.jpg.p（3KB）	智库出版物		限制开放	CC BY-NC-SA	浏览